Stefan Loren insider trades

Open-market stock purchases and sales by Stefan Loren, Director at Cellectar Biosciences, Inc, from SEC Form 4 filings since Sep 2, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • CLRB Cellectar Biosciences, Inc: other filings, last Feb 14, 2025
  • GNVC Genvec Inc: 4 buys, last Jun 16, 2017
  • MRNA Marina Biotech, Inc: other filings, last Jan 3, 2017
  • PYMX.OB Polymedix, Inc: other filings, last Mar 26, 2012

Get free alerts when Stefan Loren files a new trade →